Newbridge Financial Services Group’s Beam Therapeutics BEAM Stock Holding History
Bought
Maintained
Sold
Other funds holding BEAM
KCM
Newbridge Financial Services Group's BEAM Position: Q3 2026 in Review
Newbridge Financial Services Group held its Beam Therapeutics (BEAM) position steady in Q3 2026 at 200 shares worth $4.89K. The position accounts for ﹤0.01% of the portfolio, ranked #963.
Newbridge Financial Services Group first reported a position in BEAM in Q1 2021 and has held it in 19 quarters since. The position peaked at $32K in Q2 2021. 264 funds tracked by Wall St. Rank hold BEAM as of Q3 2026.
- Newbridge Financial Services Group held 200 shares of Beam Therapeutics worth $4.89K as of Q3 2026.
- Newbridge Financial Services Group left its Beam Therapeutics share count unchanged in Q3 2026.
- Beam Therapeutics made up ﹤0.01% of Newbridge Financial Services Group's portfolio in Q3 2026, its #963 holding.
- Newbridge Financial Services Group first reported a position in Beam Therapeutics in Q1 2021 and has held it in 19 quarters since.
- Newbridge Financial Services Group's Beam Therapeutics position peaked at $32K in Q2 2021.
- 264 funds tracked by Wall St. Rank held Beam Therapeutics as of Q3 2026.
Based on Newbridge Financial Services Group's 13F filing for Q3 2026, filed 15 Oct 2026.